Copyright
©The Author(s) 2019.
World J Gastrointest Surg. Feb 27, 2019; 11(2): 53-61
Published online Feb 27, 2019. doi: 10.4240/wjgs.v11.i2.53
Published online Feb 27, 2019. doi: 10.4240/wjgs.v11.i2.53
Table 1 Results of the studies in which endoscopic retrograde cholangiopancreatography and upper operative endoscopy for the treatment of bilio-duodenal malignant stenosis were performed
Ref. | Study design | Intervention | Patient (n) | Technical success n (%) | Clinical success n (%) | Adverse events |
Kaw et al[12], 2003 | Retrospective | Combined biliary and duodenal stenting | 18 (18 concomitant) | 17/18 (94.4) | 16/17 (94.1) | None |
Profili et al[12], 2003 | Case series | Combined biliary and duodenal stenting | 4 (4 concomitant) | 4/4 (100) | 4/4 (100) | In one case transient increase of amylase and lipase |
Vanbiervliet et al[19], 2004 | Prospective | Biliary stents were placed in patients previously treated with duodenal stents | 18 | 17/18 (94.4) | 17/18 (94.4) | None |
Maire et al[13], 2006 | Retrospective | Combined biliary and duodenal stenting | 100 (23 with bilio-duodenal stenosis; 6 concomitant) | 21/23 (91) (the study reports the overall technical success) | 21/21 (100) | None |
Mutignani et al[11], 2007 | Prospective | Combined biliary and duodenal stenting | 64 (14 concomitant) | 10/14 (71.4) | Not reported only for the patients undergone concomitant bilio-duodenal stenting | Cholecistitis (1 patient): 10% |
Moon et al[18], 2009 | Prospective | Combined biliary and duodenal stenting | 8 (8 concomitant) | 8/8 (100) (Duodenal stent); 7/8 (87.5) (Biliary stent) | 7/7 (100) | 1/8 (12.5%) mild pancreatitis |
Katsinelos et al[14], 2010 | Retrospective | Combined biliary and duodenal stenting | 39 (7 concomitant) | 32/37 (82) (the study report the overall technical success) | Not reported only for the patients undergone concomitant bilio-duodenal stenting | 3/32 (9.3%) post-sphincterotomy bleeding |
Hamada et al[16], 2011 | Retrospective | Combined biliary and duodenal stenting | 18 (4 concomitant) | 4/4 (100) | Not reported only for the patients undergone concomitant bilio-duodenal stenting | NR |
Tonozuka et al[17], 2013 | Retrospective | Combined biliary and duodenal stenting | 11 (11 concomitant: 8 EUS-BD and 3 ERCP-BD) | 3/3 (100) | 3/3 (100) | No adverse events |
Canena et al[15], 2014 | Retrospective | Combined biliary and duodenal stenting | 50 (15 concomitant) | 13/15 (86.7) | Not reported only for the patients undergone concomitant bilio-duodenal stenting | Not reported only for the patients undergone concomitant bilio-duodenal stenting |
- Citation: Mangiavillano B, Khashab MA, Tarantino I, Carrara S, Semeraro R, Auriemma F, Bianchetti M, Eusebi LH, Chen YI, De Luca L, Traina M, Repici A. Success and safety of endoscopic treatments for concomitant biliary and duodenal malignant stenosis: A review of the literature. World J Gastrointest Surg 2019; 11(2): 53-61
- URL: https://www.wjgnet.com/1948-9366/full/v11/i2/53.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v11.i2.53